Opinion statement
Infective endocarditis is an uncommon cardiac condition but is associated with significant morbidity and mortality despite advancements in diagnosis and treatment. Recent epidemiologic changes in this disease have resulted in additional challenges for treatment and improving outcome. Health care-associated infection is a growing cause of endocarditis, and the predominance of Staphylococcus aureus infection is associated with increased co-morbid medical conditions, lower rate of surgical intervention, and worse outcome. In order to reduce the high rate of complications and mortality related to endocarditis, attention to the role of antibiotic prophylaxis has been given by major cardiology societies including the American College of Cardiology, American Heart Association, and European Society of Cardiology. These recent guidelines have reduced the role of prophylaxis due to the unclear benefit, but uncertainty remains for certain pre-disposing cardiac lesions. Earlier diagnosis of endocarditis or improved prognostic tests may also reduce the complications of endocarditis by allowing earlier treatment with antibiotics or surgery, and a number of recent, preliminary studies have investigated biomarkers for improving its diagnosis or better prediction of adverse outcome. In patients with complications of endocarditis (heart failure, severe valvular regurgitation, intracardiac abscess or fistula, recurrent emboli, large vegetation or refractory infection), surgery is recommended because outcome is recognized to be poor with medical treatment alone. Recent studies of surgery for infective endocarditis have shown low operative mortality rates, particularly for patients with hemodynamic stability and non-emergent status, and a survival benefit over medical therapy alone for many of these complications. In patients with S. aureus endocarditis, surgery is less commonly performed due to co-morbid conditions, but has been shown to improve outcome and should be considered more aggressively. A growing number of studies have suggested that early surgery during the active phase of infection can be performed at low risk of operative mortality and recurrence of endocarditis, even in patients with cerebral infarction. Additional studies are needed to define the influence of surgical timing on outcome, and its potential benefit in lower-risk patients with endocarditis.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.
Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(8):676–85.
Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.
Lomas JM, Martinez-Marcos FJ, Plata A, et al. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect. 2010;16(11):1683–90.
Tribouilloy C, Rusinaru D, Sorel C, et al. Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study. Heart. 2010;96(21):1723–9.
Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354–61.
Lee JH, Burner KD, Fealey ME, et al. Prosthetic valve endocarditis: clinicopathological correlates in 122 surgical specimens from 116 patients (1985–2004). Cardiovasc Pathol. 2011;20(1):26–35.
Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis. 2010;10(8):527–35.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.
Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51(2):131–40.
Knudsen JB, Fuursted K, Petersen E, et al. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med. 2010;123(12):1121–7.
Shiue AB, Stancoven AB, Purcell JB, et al. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis. Am J Cardiol. 2010;106(7):1011–5.
Stancoven AB, Shiue AB, Khera A, et al. Association of Troponin T, detected with highly sensitive assay, and outcomes in infective endocarditis. Am J Cardiol. May 18 2011.
Lalani T, Cabell CH, Benjamin DK, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121(8):1005–13.
Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141(1):98–106 e101–102.
Kim DH, Kang DH, Lee MZ, et al. Impact of early surgery on embolic events in patients with infective endocarditis. Circulation. 2010;122(11 Suppl):S17–22.
Disclosure
A. Wang has been a reviewer for a defendant in a legal case, receives royalties from Humana Press (for a book on valvular heart disease), and has received payment from the American College of Cardiology to develop educational presentations (Cardiosource update on valvular heart disease).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, A. Recent Progress in the Understanding of Infective Endocarditis. Curr Treat Options Cardio Med 13, 586–594 (2011). https://doi.org/10.1007/s11936-011-0146-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11936-011-0146-5